Koninklijke Philips (PHG) Revenue Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 4.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.73% |
| Dec 31, 2025 | 2.36% |
| Sep 30, 2025 | 4.99% |
| Jun 30, 2025 | 3.28% |
| Mar 31, 2025 | -0.67% |
| Dec 31, 2024 | -1.59% |
| Sep 30, 2024 | -0.64% |
| Jun 30, 2024 | -1.93% |
| Mar 31, 2024 | -0.88% |
| Dec 31, 2023 | -4.44% |
| Sep 30, 2023 | -1.88% |
| Jun 30, 2023 | 3.60% |
| Mar 31, 2023 | 3.14% |
| Dec 31, 2022 | -5.69% |
| Sep 30, 2022 | -6.00% |
| Jun 30, 2022 | -5.30% |
| Mar 31, 2022 | -2.32% |
| Dec 31, 2021 | -3.92% |
| Sep 30, 2021 | -0.72% |
| Jun 30, 2021 | -0.15% |
| Mar 31, 2021 | -1.58% |
| Dec 31, 2020 | 40.11% |
| Sep 30, 2020 | -29.43% |
| Jun 30, 2020 | -21.81% |
| Mar 31, 2020 | -1.75% |
| Dec 31, 2019 | 25.99% |
| Sep 30, 2019 | 7,186.61% |
| Jun 30, 2019 | -16.43% |
| Mar 31, 2019 | 3.79% |
| Dec 31, 2018 | -37.86% |
| Sep 30, 2018 | -8.28% |
| Jun 30, 2018 | -8.14% |
| Mar 31, 2018 | -7.06% |
| Dec 31, 2017 | -44.51% |
| Mar 31, 2016 | -15.22% |
| Dec 31, 2015 | -4.41% |
| Sep 30, 2015 | -32.26% |
| Jun 30, 2015 | -23.55% |
| Mar 31, 2015 | -4.65% |
| Dec 31, 2014 | 3.96% |
| Mar 31, 2013 | 0.13% |
| Dec 31, 2012 | 41.55% |